BioMarin Pharmaceutical Inc. is a verified, publicly traded biotechnology leader (NASDAQ: BMRN) with over $2 billion in annual revenue and exceptional real-world utility in treating rare genetic disorders. While the entity itself falls into the highest tier of scale and impact (400-700+), the specific submission provided contains significant inaccuracies (e.g., claiming 'everyone' as the audience and 'most people' as users) and lacks effort. The final score reflects the verified massive scale and innovation of the company, heavily penalized by the low quality factors of the submission data regarding traction and reach.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline